Stay hydrated: Drinking plenty of water helps thin mucus, making it easier to drain. Using a humidifier, placing a warm ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

I recently took a generic 12-hour, maximum-strength nasal decongestant to manage typical sinus pressure and congestion.

The agency said an extensive review of available data determined that the ingredient, oral phenylephrine, doesn’t actually ...

Citing topline data from their Phase 3 WAYPOINT trial, the companies said that the antibody therapy reduced the size of nasal ...

Participants in the trial were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]). 1 Dr. Joseph Han, Vice Chair of Rhinology & Endoscopic Sinus and Skull Base ...

AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder characterised by ...

Availability NasalFresh MD is now available for purchase at CVS stores nationwide and online at CVS.com and Nasalfreshmd.com.